Blog
RSS FeedPosted by Michael Wonder on 08 May 2019
PTAC recommends the use of pembrolizumab as a first-line treatment for patients with advanced non-small cell lung cancer
8 May 2019 - The focus now shifts to when will the PTAC recommendation be implemented. ...
Posted by Michael Wonder on 08 May 2019
New hope for cancer patients accessing leading-edge unfunded drugs
8 May 2019 - Peter Fergusson, CEO of Leukaemia & Blood Cancer New Zealand is heartened to hear that Pharmac ...
Posted by Michael Wonder on 08 May 2019
Blood cancer patients advocate pleads for treatment funding
8 May 2019 - Patient advocacy group Myeloma New Zealand has joined forces with other patient groups to petition Parliament ...
Posted by Michael Wonder on 07 May 2019
RFP - supply of the levonorgestrel intrauterine system
6 May 2019 - PHARMAC invites proposals for the supply of the levonorgestrel intrauterine system in New Zealand. ...
Posted by Michael Wonder on 07 May 2019
Cancer sufferers deliver eight PHARMAC funding petitions to Parliament
7 May 2019 - People desperately seeking cancer treatment which could extend their lives by years have called on politicians to ...
Posted by Michael Wonder on 07 May 2019
Hundreds rally at Parliament to present petitions for better PHARMAC funding
7 May 2019 - Deputy Prime Minister and New Zealand First leader Winston Peter has thrown his weight behind trialling ...
Posted by Michael Wonder on 06 May 2019
'Well-being' budget should fund cancer treatment
7 May 2019 - Hundreds of cancer patients and survivors will turn up at Parliament today to protest against Pharmac, ...
Posted by Michael Wonder on 06 May 2019
Parliament rally to present eight petitions for more PHARMAC funding for medicines
7 May 2019 - A woman who suffers a rare disorder is just out of hospital but she's determined to ...
Posted by Michael Wonder on 06 May 2019
PHARMAC Chairman backs early access scheme for new drugs
7 May 2019 - PHARMAC board chairman Steve Maharey is backing an early access scheme that would give patients access ...
Posted by Michael Wonder on 06 May 2019
Proposal to widen access to etanercept and award sole supply
3 May 2019 - PHARMAC is proposing to make changes to the funding of etanercept, a biologic medicine used to ...
Posted by Michael Wonder on 06 May 2019
Decision to amend the distribution and access criteria for dasatinib (Sprycel)
3 May 2019 - PHARMAC has a made a decision to change the distribution arrangements and access criteria for the ...
Posted by Michael Wonder on 06 May 2019
PHARMAC funding: how it works - and the changes its critics want
6 May 2019 - PHARMAC will again be thrust into the spotlight tomorrow when New Zealanders rally at Parliament calling ...
Posted by Michael Wonder on 01 May 2019
Why PHARMAC won't fund lifesaving EpiPens
1 May 2019 - Epipens can be the difference between life and death for people who have food allergies but, ...
Posted by Michael Wonder on 30 Apr 2019
New Zealand Pharmaceutical Schedule - 1 May 2019 update
1 May 2019 - The May 2019 issue of the New Zealand Pharmaceutical Schedule is now available and in effect. ...
Posted by Michael Wonder on 29 Apr 2019
Health groups to present multiple petitions
30 April 2019 - Health groups marching to Parliament to present multiple petitions ...